EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting

-

Gynecologic Cancer Track:

Poster Session

Friday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021

Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer

Poster Board: 10, Location: E450a

Discussion Session

Friday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)

Location: E354b